Spectacular Market Launches Key To Enduring Success Of Brands In APAC - IMS Health
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Following studies on the launch of patented brands in the Asia-Pacific market, IMS Health said less than 20 percent of brands perform well if they do not strike significant success within the first six months of their launches
You may also be interested in...
Emerging Markets Earnings Roundup: BMS, Pfizer (Part 2)
BMS elaborated on its plans to ease out of the emerging market explosion in demand for diabetes treatments as it moves to develop new therapies in immune-oncology. Pfizer saw China revenues rise smartly in the fourth quarter and Lipitor sales standout in emerging markets.
BMS Dives Deeper Into China With First Discovery Partnership
BMS doubling down in China with discovery deal with Beijing’s Tsinghua University and plans to ramp up in diabetes and hepatitis.
BMS Dives Deeper Into China With First Discovery Partnership
BMS doubling down in China with discovery deal with Beijing’s Tsinghua University and plans to ramp up in diabetes and hepatitis.